Propanc Biopharma, Inc. | Purchase Agreements | Business Contracts

Securities Purchase Agreement, dated February 14, 2023, by and between the Company and ONE44 Capital LLC (Filed With SEC on February 21, 2023)

Securities Purchase Agreement, dated October 6, 2022, by and between the Company and Red Road Holdings Corporation (Filed With SEC on October 12, 2022)

Securities Purchase Agreement, dated September 21, 2022, by and between the Company and GS Capital Partners, LLC (Filed With SEC on September 27, 2022)

Securities Purchase Agreement, dated August 15, 2022, issued by the Company to ONE44 Capital LLC (Filed With SEC on August 18, 2022)

Securities Purchase Agreement, dated August 12, 2022, by and between the Company and GS Capital Partners, LLC (Filed With SEC on August 18, 2022)

Securities Purchase Agreement, dated June 30, 2022, by and between the Company and 1800 Diagonal Lending LLC (Filed With SEC on July 7, 2022)

Securities Purchase Agreement, dated May 12, 2022, by and between the Company and 1800 Diagonal Lending LLC (Filed With SEC on May 18, 2022)

Securities Purchase Agreement, dated April 12, 2022, by and between the Company and Sixth Street Lending LLC (Filed With SEC on April 18, 2022)

Securities Purchase Agreement, dated March 29, 2022, by and between the Company and ONE44 Capital LLC (Filed With SEC on April 1, 2022)

Securities Purchase Agreement, dated March 7, 2022, by and between the Company and Sixth Street Lending LLC (Filed With SEC on March 10, 2022)

Securities Purchase Agreement, dated January 3, 2022, by and between the Company and Sixth Street Lending LLC (Filed With SEC on January 10, 2022)

Securities Purchase Agreement, dated December 7, 2021, by and between the Company and ONE44 Lending LLC (Filed With SEC on December 13, 2021)

Securities Purchase Agreement, dated November 26, 2021, by and between the Company and Sixth Street Lending LLC (Filed With SEC on December 1, 2021)

Securities Purchase Agreement, dated October 21, 2021, by and between the Company and Sixth Street Lending LLC (Filed With SEC on October 27, 2021)

Securities Purchase Agreement, dated September 22, 2021, by and between the Company and Geneva Roth Remark Holdings, Inc (Filed With SEC on September 28, 2021)

Securities Purchase Agreement, dated August 19, 2021, by and between the Company and Geneva Roth Remark Holdings, Inc (Filed With SEC on August 25, 2021)

Securities Purchase Agreement, dated March 16, 2021, by and between the Company and Geneva Roth Remark Holdings, Inc (Filed With SEC on March 19, 2021)

Securities Purchase Agreement, dated January 5, 2021, by and between the Company and Geneva Roth Remark Holdings, Inc (Filed With SEC on January 11, 2021)

Securities Purchase Agreement, dated December 10, 2020, by and between the Company and GW Holdings Group, LLC (Filed With SEC on December 16, 2020)

Securities Purchase Agreement, dated December 2, 2020, by and between the Company and Geneva Roth Remark Holdings, Inc (Filed With SEC on December 7, 2020)

Form of Securities Purchase Agreement (Filed With SEC on April 3, 2020)

Form of Second Securities Purchase Agreement (Filed With SEC on January 17, 2020)

Form of First Securities Purchase Agreement (Filed With SEC on January 17, 2020)

Form of Securities Purchase Agreement (Filed With SEC on October 15, 2019)

Form of Securities Purchase Agreement (Filed With SEC on October 8, 2019)

Securities Purchase Agreement dated August 30, 2019, by and between Propanc Biopharma, Inc. and Auctus Fund LLC (Filed With SEC on September 9, 2019)

Securities Purchase Agreement dated July 30, 2019, by and between Propanc Biopharma, Inc. and Odyssey Capital Funding LLC (Filed With SEC on August 6, 2019)

Securities Purchase Agreement, dated July 3, 2019, by and between the Company and Power Up Lending Group Ltd (Filed With SEC on July 10, 2019)

Form of Securities Purchase Agreement (Filed With SEC on June 14, 2019)

Securities Purchase Agreement, dated May 23, 2019, by and between the Company and Redstart Holdings Corp (Filed With SEC on May 30, 2019)

Equity Purchase Agreement, dated February 25, 2019, by and between the Company and the Investor (Filed With SEC on February 25, 2019)

Propanc Biopharma, Inc. (87) | Purchase Agreements (31)